Yarong Guo

1.7k total citations
36 papers, 1.4k citations indexed

About

Yarong Guo is a scholar working on Electrical and Electronic Engineering, Molecular Biology and Control and Systems Engineering. According to data from OpenAlex, Yarong Guo has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Electrical and Electronic Engineering, 10 papers in Molecular Biology and 8 papers in Control and Systems Engineering. Recurrent topics in Yarong Guo's work include High-Voltage Power Transmission Systems (8 papers), Power Systems Fault Detection (7 papers) and HVDC Systems and Fault Protection (6 papers). Yarong Guo is often cited by papers focused on High-Voltage Power Transmission Systems (8 papers), Power Systems Fault Detection (7 papers) and HVDC Systems and Fault Protection (6 papers). Yarong Guo collaborates with scholars based in China, United States and Australia. Yarong Guo's co-authors include Zhengguo Zhang, Xiaoming Fang, Qiong Liu, Tianxiang Chen, Zhihong Chen, Zehao Li, Yihe Yan, Qiang Du, David A. Geller and Junmei Jia and has published in prestigious journals such as Analytical Chemistry, Applied Catalysis B: Environmental and Biochemical and Biophysical Research Communications.

In The Last Decade

Yarong Guo

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yarong Guo China 13 1000 843 479 189 105 36 1.4k
Pingping Niu China 19 549 0.5× 585 0.7× 230 0.5× 116 0.6× 56 0.5× 41 1.1k
Jixiang Xia China 10 667 0.7× 552 0.7× 385 0.8× 108 0.6× 50 0.5× 14 970
Rui Sui China 17 844 0.8× 396 0.5× 435 0.9× 122 0.6× 84 0.8× 30 1.1k
Xiao Ying Liu China 21 541 0.5× 510 0.6× 1.0k 2.1× 284 1.5× 100 1.0× 44 1.7k
Pengfei Yue China 10 654 0.7× 581 0.7× 339 0.7× 114 0.6× 23 0.2× 17 957
Bing Qiu China 18 232 0.2× 424 0.5× 172 0.4× 283 1.5× 151 1.4× 49 1.0k
Junfeng Qiu China 20 240 0.2× 346 0.4× 139 0.3× 285 1.5× 157 1.5× 53 1.3k
Xue Fang China 15 228 0.2× 607 0.7× 167 0.3× 89 0.5× 53 0.5× 33 856
Huajian Chen China 22 234 0.2× 494 0.6× 167 0.3× 204 1.1× 53 0.5× 57 1.2k
Chen Zhao China 19 306 0.3× 300 0.4× 176 0.4× 175 0.9× 51 0.5× 51 822

Countries citing papers authored by Yarong Guo

Since Specialization
Citations

This map shows the geographic impact of Yarong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yarong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yarong Guo more than expected).

Fields of papers citing papers by Yarong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yarong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yarong Guo. The network helps show where Yarong Guo may publish in the future.

Co-authorship network of co-authors of Yarong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yarong Guo. A scholar is included among the top collaborators of Yarong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yarong Guo. Yarong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Yuze, Yuheng Yan, Yarong Guo, et al.. (2025). Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis. Journal of Hematology & Oncology. 18(1). 24–24. 12 indexed citations
3.
4.
Liu, Feng, et al.. (2024). Research progress on prognostic factors of gallbladder carcinoma. Journal of Cancer Research and Clinical Oncology. 150(10). 447–447.
5.
Li, Yanjun, et al.. (2024). ETV7 promotes colorectal cancer progression through upregulation of IFIT3. Functional & Integrative Genomics. 24(1). 8–8. 2 indexed citations
6.
Liu, Yang, et al.. (2024). KLF7 Promotes Hepatocellular Carcinoma Progression Through Regulating SLC1A5‐Mediated Tryptophan Metabolism. Journal of Cellular and Molecular Medicine. 28(23). e70245–e70245. 5 indexed citations
7.
Guo, Yarong, et al.. (2023). Contrast-Enhanced CT-Based Deep Learning Radiomics Nomogram for the Survival Prediction in Gallbladder Cancer. Academic Radiology. 31(6). 2356–2366. 7 indexed citations
8.
Guo, Yarong, et al.. (2021). KLF7/VPS35 axis contributes to hepatocellular carcinoma progression through CCDC85C-activated β-catenin pathway. Cell & Bioscience. 11(1). 73–73. 28 indexed citations
9.
Li, Bin, et al.. (2021). Improved Differential-current protection For AC Transmission Line Connecting Renewable Energy Power Plant And MMC-HVDC System. 2021 IEEE Sustainable Power and Energy Conference (iSPEC). 787–791. 1 indexed citations
10.
Mei, Ping, et al.. (2021). TRIM21 improves apatinib treatment in gastric cancer through suppressing EZH1 stability. Biochemical and Biophysical Research Communications. 586. 177–184. 23 indexed citations
11.
Guo, Yarong, Na Zhu, Junmei Jia, et al.. (2021). Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β‑catenin. Molecular Medicine Reports. 24(6). 5 indexed citations
12.
Guo, Yarong, Jun Xu, Qiang Du, Yihe Yan, & David A. Geller. (2021). IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin. Translational Oncology. 14(6). 101059–101059. 35 indexed citations
13.
Yan, Yihe, Leting Zheng, Qiang Du, et al.. (2021). Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC). Cancer Letters. 506. 95–106. 56 indexed citations
14.
Guo, Yarong, et al.. (2019). MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1.. PubMed. 11(7). 4516–4523. 39 indexed citations
15.
Guo, Yarong, et al.. (2019). The prognostic value of homeobox B7 expression in patients with hepatocellular carcinoma.. PubMed. 12(7). 2682–2690. 1 indexed citations
16.
17.
Guo, Yarong, Qiong Liu, Zehao Li, Zhengguo Zhang, & Xiaoming Fang. (2017). Enhanced photocatalytic hydrogen evolution performance of mesoporous graphitic carbon nitride co-doped with potassium and iodine. Applied Catalysis B: Environmental. 221. 362–370. 142 indexed citations
18.
19.
20.
Guo, Yarong, Yun Zhang, Xiaohong Guo, et al.. (2014). Insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway. Hepatology International. 9(1). 130–141. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pingping Niu Breakdown of academic impact, for papers by Jixiang Xia Breakdown of academic impact, for papers by Rui Sui Breakdown of academic impact, for papers by Xiao Ying Liu Breakdown of academic impact, for papers by Pengfei Yue Breakdown of academic impact, for papers by Bing Qiu Breakdown of academic impact, for papers by Junfeng Qiu Breakdown of academic impact, for papers by Xue Fang Breakdown of academic impact, for papers by Huajian Chen Breakdown of academic impact, for papers by Chen Zhao
Rankless by CCL
2026